Hepatocellular carcinoma, decompensation, and mortality based on hepatitis C treatment: A prospective cohort study

doi:10.3748/wjg.v28.i30.4182

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 30

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3445)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

224

WORD

HTML

1632

Figures (1-3)

324

Tables (1-5)

189

Sum=2412

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

262

Download

771

Sum=1033

Aug 14, 2022 (publication date) through May 17, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Aug 14, 2022; 28(30): 4182-4200
Published online Aug 14, 2022. doi: 10.3748/wjg.v28.i30.4182

Full Size Figure Download Figure

Figure 1 Patient flow diagram. DAA: Direct-acting antivirals; dLC: Decompensated liver cirrhosis; HBV: Hepatitis B virus; HCC: Hepatocellular carcinoma; HCV: Hepatitis C virus; IBT: Interferon-based treatment; HIV: Human immunodeficiency virus; LT: Liver transplantation.

Citation: Choi GH, Jang ES, Kim YS, Lee YJ, Kim IH, Cho SB, Lee HC, Jang JW, Ki M, Choi HY, Baik D, Jeong SH. Hepatocellular carcinoma, decompensation, and mortality based on hepatitis C treatment: A prospective cohort study. World J Gastroenterol 2022; 28(30): 4182-4200
URL: https://www.wjgnet.com/1007-9327/full/v28/i30/4182.htm
DOI: https://dx.doi.org/10.3748/wjg.v28.i30.4182